Question 1

Does Schonfeld Strategic Advisors own AXSM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Schonfeld Strategic Advisors holds 35,608 shares of AXSM (Axsome Therapeutics), worth $8.7M.

Question 2

How many shares of AXSM does Schonfeld Strategic Advisors own?

Accepted Answer

As of its Q2 2026 13F, Schonfeld Strategic Advisors holds 35,608 shares of AXSM (Axsome Therapeutics).

Question 3

What is Schonfeld Strategic Advisors' AXSM position worth?

Accepted Answer

As of its Q2 2026 13F, Schonfeld Strategic Advisors' AXSM position is worth $8.7M.

Question 4

Is Schonfeld Strategic Advisors buying or selling AXSM?

Accepted Answer

In Q2 2026, Schonfeld Strategic Advisors opened a new AXSM position of 35,608 shares.

Question 5

When did Schonfeld Strategic Advisors first buy AXSM?

Accepted Answer

Schonfeld Strategic Advisors already held AXSM in its Q1 2019 13F, the earliest on record, and has listed it in 22 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	New	35,608	—	$8.7M	0.0%	$244.77	38
2025-Q3	Exited	0	-100.0%	$0	0.0%	$121.45	0
2025-Q2	Decreased	2,490	-89.7%	$259,931	0.0%	$104.39	0
2025-Q1	Decreased	24,200	-4.7%	$2.8M	0.0%	$116.63	0
2024-Q4	Decreased	25,380	-69.0%	$2.1M	0.0%	$84.61	0
2024-Q3	Increased	81,997	+39.2%	$7.4M	0.0%	$89.87	36